Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Dasatinib
Related studies linked through entity extraction aliases.
Pilot Trial for Treatment of Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database
- Status
- COMPLETED
- Phase
- N/A
Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- NA
A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL
- Status
- UNKNOWN
- Phase
- NA
ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Efficacy and Safety of Switching to Flumatinib Versus Dasatinib After Imatinib-related Low-grade Adverse Events in CML-CP Patients
- Status
- UNKNOWN
- Phase
- PHASE4
Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction
- Status
- COMPLETED
- Phase
- PHASE2
Asciminib Roll-over Study
- Status
- RECRUITING
- Phase
- PHASE4
Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
- Status
- RECRUITING
- Phase
- PHASE2
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ALSENLITE: Senolytics for Alzheimer's Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
- Status
- SUSPENDED
- Phase
- PHASE2
A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.
- Status
- COMPLETED
- Phase
- PHASE1